Diamond Member Pelican Press 0 Posted August 16, 2024 Diamond Member Share Posted August 16, 2024 This is the hidden content, please Sign In or Sign Up Pfizer, BioNtech say combined flu-COVID vaccine misses a main goal of Phase 3 trial, ET HealthWorld data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== By Deena Beasley London: Pfizer and BioNTech said a late-stage trial of their experimental mRNA vaccine to protect against influensa and COVID-19 found the combination shot ******* to meet one of the study’s two main goals and they are evaluating next steps. The drugmakers said on Friday the Phase 3 trial showed the vaccine elicited a robust influensa A immune response, compared to a standard flu vaccine, but showed weaker results against the influensa B strain. The formulation showed similar responses against SARS-CoV-2 as the companies’ COVID-19 vaccine. “We remain optimistic about our combination COVID-19 and influensa program, for which we are evaluating the next steps,” Annaliesa Anderson, Pfizer’s head of vaccine research and development, said in a statement. The companies said they are discussing the findings with health authorities and evaluating adjustments to the candidate. The trial, which compared the experimental vaccine to a licensed influensa vaccine and the companies’ COVID-19 vaccine given at the same visit, enrolled 8,000 healthy adults. The drugmakers said no safety issues with the combination vaccine have been identified. Pfizer also said a Phase 2 trial of its second-generation mRNA flu vaccine candidate showed that the formulation elicited robust influensa A and B responses, with no safety issues reported. It said data from the 450-patient flu vaccine trial would be made available at a later date. (Reporting by Deena Beasley; Editing by Jamie Freed) Published On Aug 16, 2024 at 10:00 PM IST Join the community of 2M+ industry professionals Subscribe to our newsletter to get latest insights & analysis. data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== Download ETHealthworld App Get Realtime updates Save your favourite articles data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== Scan to download App data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///ywAAAAAAQABAAACAUwAOw== This is the hidden content, please Sign In or Sign Up #Pfizer #BioNtech #combined #fluCOVID #vaccine #misses #main #goal #Phase #trial #HealthWorld This is the hidden content, please Sign In or Sign Up This is the hidden content, please Sign In or Sign Up 0 Quote Link to comment https://hopzone.eu/forums/topic/101291-pfizer-biontech-say-combined-flu-covid-vaccine-misses-a-main-goal-of-phase-3-trial-et-healthworld/ Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.